Oximio Revenue and Competitors

Location

N/A

Total Funding

Logistics

Industry

Estimated Revenue & Valuation

  • Oximio's estimated annual revenue is currently $53.3M per year.(i)
  • Oximio's estimated revenue per employee is $335,500

Employee Data

  • Oximio has 159 Employees.(i)
  • Oximio grew their employee count by 5% last year.

Oximio's People

NameTitleEmail/Phone
1
Global Transport and Partner Depot ManagerReveal Email/Phone
2
Global Project ManagerReveal Email/Phone
3
Warehouse ManagerReveal Email/Phone
4
Project ManagerReveal Email/Phone
5
Key Account ManagerReveal Email/Phone
6
Senior Business AdvisorReveal Email/Phone
7
Senior Project SpecialistReveal Email/Phone
8
Import Export SpecialistReveal Email/Phone
9
Logistics SpecialistReveal Email/Phone
10
Project SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$18.1M66-6%N/AN/A
#2
$34.2M1128%N/AN/A
#3
$262.7M68925%N/AN/A
#4
$35.1M115-13%N/AN/A
#5
$3.3M18-10%N/AN/A
#6
$28.1M9219%N/AN/A
#7
$10.7M44-20%N/AN/A
#8
$16.2M59-8%N/AN/A
#9
$350.6M8210%N/AN/A
#10
$263.8M6923%N/AN/A
Add Company

What Is Oximio?

keywords:N/A

N/A

Total Funding

159

Number of Employees

$53.3M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Oximio News

2022-04-17 - Thread acquires CureClick to improve trial awareness, access

In this whitepaper, Oximio outlines the dynamics of today's clinical trial market in Africa, including the key challenges the region is facing...

2022-04-17 - Panthera raises funds to expedite expansion of clinical trial sites

by Oximio. Enter your details here to receive your free Whitepaper.

2022-03-30 - The effect of post-Brexit status on clinical trial logistics

"The UK will remain an important player from a health economics point of view.” One year on from Brexit, Clinical Trials Arena talks to Oximio...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$31.5M15961%N/A
#2
$50.7M1596%N/A
#3
$75M15951%N/A
#4
$24.5M159N/AN/A
#5
$25.4M159N/AN/A